Processing and presentation of tumor antigens and vaccination strategies-Reference-Cited by-同舟云学术

Processing and presentation of tumor antigens and vaccination strategies

Published:2006-02 Issue:1 Volume:18 Page:98-104
ISSN:0952-7915
Container-title:Current Opinion in Immunology
language:en
Short-container-title:Current Opinion in Immunology

Author:

Bruggen Pierre van der,Eynde Benoît J Van den

Publisher

Elsevier BV

Subject

Immunology,Immunology and Allergy

Reference57 articles.

1. Van den Eynde B, van der Bruggen P: Peptide database of T-cell defined tumor antigens. URL: http://www.cancerimmunity.org/peptidedatabase/Tcellepitopes.htm.

2. Rapid degradation of a large fraction of newly synthesized proteins by proteasomes;Schubert;Nature,2000

3. Quantitating protein synthesis, degradation, and endogenous antigen processing;Princiotta;Immunity,2003

4. Immune recognition of a human renal cancer antigen through post-translational protein splicing;Hanada;Nature,2004

5. An antigenic peptide produced by peptide splicing in the proteasome;Vigneron;Science,2004

Cited by 72 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Caged aminoluciferin probe for bioluminescent immunoproteasome activity analysis;RSC Chemical Biology;2024

2. In vitro proteasome processing of neo-splicetopes does not predict their presentation in vivo;eLife;2021-04-20

3. Naringenin Enhances the Antitumor Effect of Therapeutic Vaccines by Promoting Antigen Cross-Presentation;The Journal of Immunology;2019-12-23

4. Monitoring the Immunoproteasome in Live Cells Using an Activity-Based Peptide–Peptoid Hybrid Probe;Journal of the American Chemical Society;2019-03-13

5. Targeting Autophagy in ALK-Associated Cancers;Cancers;2017-11-27